DB21, Galectin-1 Antagonist

DB21, Galectin-1 Antagonist, is a peptidomimetic conjugated with dibenzofuran, serving as an allosteric inhibitor of galectin-1 (GAL1) interactions with glycans on cell surfaces. This compound enhances the inhibition of angiogenesis and tumor growth in melanoma, lung adenocarcinoma, and ovarian cancer models [1].

C(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CO)N)=O)C(C)C)=O)CCC(N)=O)=O)CCC)=O)CCCCN)=O)CC(C)C)=O)C1=C2C(C=3C(O2)=C(CCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)C)=O)CC(N)=O)=O)CC(C)C)=O)CCCCN)=O)[C@@H](C)C)=O)[C@H](CC)C)=O)[C@H](CC)C)=O)C=CC3)=CC=C1